AIMS: Cardiovascular conditions are reported to be the most frequent cause of death in patients with chronic obstructive pulmonary disease (COPD). However, it remains unsettled whether severity of COPD per se is associated with coronary artery disease (CAD) independent of traditional cardiovascular risk factors. The aim of this study was to examine the relationship between the presence and severity of COPD and the amount of coronary artery calcium deposit, an indicator of CAD and cardiac risk, in a large population of current and former long-term smokers. METHODS AND RESULTS: In this cross-sectional study, long-term smokers without clinically manifested CAD were recruited from the Danish Lung Cancer Screening Trial and classified according to lung function by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Coronary artery calcium deposit as a measure of subclinical CAD and cardiac risk was evaluated with multi detector computed tomography and the Agatston coronary artery calcium score (CACS). Participants were categorized into five CACS risk classification groups according to the CACS. The population (n = 1535) consisted of 41% participants without COPD, 28% with mild, and 31% with moderate-to-severe COPD (n = 46 with severe COPD). In addition to age, male gender, hypertension, hypercholesterolaemia, and continued smoking, COPD according to GOLD classification were independent predictors of a higher CACS risk classification group in multivariable analysis [odds ratio (OR): 1.28 (1.01-1.63) and OR: 1.32 (1.05-1.67), for mild and moderate-to-severe COPD, respectively, compared with no COPD]. CONCLUSION: COPD in long-term smokers is independently correlated with the CACS, while COPD severity per se does not show a dose-response relationship.
AIMS: Cardiovascular conditions are reported to be the most frequent cause of death in patients with chronic obstructive pulmonary disease (COPD). However, it remains unsettled whether severity of COPD per se is associated with coronary artery disease (CAD) independent of traditional cardiovascular risk factors. The aim of this study was to examine the relationship between the presence and severity of COPD and the amount of coronary artery calcium deposit, an indicator of CAD and cardiac risk, in a large population of current and former long-term smokers. METHODS AND RESULTS: In this cross-sectional study, long-term smokers without clinically manifested CAD were recruited from the Danish Lung Cancer Screening Trial and classified according to lung function by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Coronary artery calcium deposit as a measure of subclinical CAD and cardiac risk was evaluated with multi detector computed tomography and the Agatston coronary artery calcium score (CACS). Participants were categorized into five CACS risk classification groups according to the CACS. The population (n = 1535) consisted of 41% participants without COPD, 28% with mild, and 31% with moderate-to-severe COPD (n = 46 with severe COPD). In addition to age, male gender, hypertension, hypercholesterolaemia, and continued smoking, COPD according to GOLD classification were independent predictors of a higher CACS risk classification group in multivariable analysis [odds ratio (OR): 1.28 (1.01-1.63) and OR: 1.32 (1.05-1.67), for mild and moderate-to-severe COPD, respectively, compared with no COPD]. CONCLUSION:COPD in long-term smokers is independently correlated with the CACS, while COPD severity per se does not show a dose-response relationship.
Authors: Michelle John; Tricia M McKeever; Maath Al Haddad; Ian P Hall; Ian Sayers; John R Cockcroft; Charlotte E Bolton Journal: Chron Respir Dis Date: 2016-03-10 Impact factor: 2.444
Authors: Surya P Bhatt; Ella A Kazerooni; John D Newell; John E Hokanson; Matthew J Budoff; Chandra A Dass; Carlos H Martinez; Sandeep Bodduluri; Francine L Jacobson; Andrew Yen; Mark T Dransfield; Carl Fuhrman; Hrudaya Nath Journal: Chest Date: 2018-06-08 Impact factor: 9.410
Authors: Thomas Gaisl; Christian Schlatzer; Esther I Schwarz; Mathias Possner; Julia Stehli; Noriane A Sievi; Christian F Clarenbach; Damini Dey; Piotr J Slomka; Philipp A Kaufmann; Malcolm Kohler Journal: PLoS One Date: 2015-05-26 Impact factor: 3.240
Authors: Zahra Sedghi Gamechi; Lidia R Bons; Marco Giordano; Daniel Bos; Ricardo P J Budde; Klaus F Kofoed; Jesper Holst Pedersen; Jolien W Roos-Hesselink; Marleen de Bruijne Journal: Eur Radiol Date: 2019-01-23 Impact factor: 5.315
Authors: Amy Groenewegen; Victor W Zwartkruis; Michiel Rienstra; Monika Hollander; Hendrik Koffijberg; Maarten Jan Maria Cramer; Yvonne T van der Schouw; Arno W Hoes; Rudolf A de Boer; Frans H Rutten Journal: BMJ Open Date: 2021-10-26 Impact factor: 2.692
Authors: Vivian Feng; Shankar Tumati; Ruoding Wang; Kritleen K Bawa; Damien Gallagher; Nathan Herrmann; Susan Marzolini; Paul Oh; Ana Andreazza; Krista L Lanctôt Journal: Brain Sci Date: 2022-08-12
Authors: Siew-Mooi Ching; Yook-Chin Chia; Marleen A H Lentjes; Robert Luben; Nicholas Wareham; Kay-Tee Khaw Journal: BMC Public Health Date: 2019-05-03 Impact factor: 3.295